Researchers from three university hospitals have developed a technology to synthesize RNA protein suitable for treating congenital retinal diseases.Congenital retinal disease, caused by a genetic mutation, is the leading cause of blindness in children inflicting about two million patients worldwide,
Pfizer’s Vyndamax (tafamidis), a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), got in the European Society of Cardiology’s (ESC) list of recommended drugs for heart failure.However, observers said it is uncertain whether the treatment would be reimbursable in Korea because of its hig
Korea marked a new record in the share of infections with unknown routes on Wednesday, officials said.There were 23,992 new confirmed cases reported to the quarantine authorities in the past two weeks. About 36.7 percent of the total, or 8,815, are cases with unknown infection routes. The percentage
Samsung Medical Center said Wednesday that it has succeeded subretinal injection of gene therapy Luxturna (ingredient: voretigene neparvovec) in a patient with inherited retinal degeneration for the first time in Korea.Luxturna received approval from the U.S. Food and Drug Administration in 2017 as
JW Bioscience’s technology using tryptophanyl tRNA synthetase (WRS) as a biomarker for early diagnosis of sepsis, or blood poisoning, has been registered as a source technology from the European Patent Office.The company has secured an advantageous position in the global in-vitro diagnostic market w
Medytox said Wednesday that AbbVie has returned the rights concerning MT10109L, a botulinum toxin candidate, to the Korean company.Medytox licensed out the candidate to Allergan, which is now part of AbbVie, in 2013 and granted the exclusive right to develop and commercialize MT10109L in countries a
Genome & Company, an immunotherapy developer, has taken the first to jump into the CDMO industry by acquiring a U.S. microbiome company, List Biological Laboratory (List Labs).At an online news conference on Wednesday, the company presented its mid-to-long-term vision of becoming a fully integrated
As the U.S. plans to expand the global Covid-19 vaccine supply chain, Korean contract development and manufacturing organizations (CDMOs) should grab an opportunity to attract U.S. investment, a local biotech industry group said.Quoting White House Covid-19 advisor Jeff Zients, Korea Biotech Industr
The Ministry of Food and Drug Safety confirmed that the risk of harm to the human body of N-nitroso-varenicline (NNV) among medicines containing varenicline, a smoking cessation treatment aid, was very low.Varenicline is the main ingredient in Pfizer's anti-nicotine therapy Champix. Thirty-four Kore
inno.N said that it would collaborate with Novacell technology to develop a peptide-based autoimmune disease treatment.Under the accord, Novacell will discover candidate substances for anti-inflammatory peptides, and inno.N plans to conduct additional research and clinical trials on the substance wi
The Korean Medical Association (KMA) said the health authorities should restrict the general public's use of Covid-19 home test kits.The doctors' group said that reckless use of self-test kits partially contributed to the continuing spike in Covid-19 cases despite the strictest Level 4 social distan
The health authorities said they would recognize vaccine trial participants as fully vaccinated to encourage participation in local Covid-19 vaccine studies.Earlier on Aug. 19, the Ministry of Health and Welfare announced plans to support quick phase 3 trials of Covid-19 vaccines and issue vaccinati
Biopharmaceutical companies are the biggest beneficiaries of the Covid-19 outbreak, but financial reports of such companies showed that despite their hefty gains, they offered little in social contributions.Local drugmakers have significantly improved their performance due to the outbreak of Covid-1
Korea may change its quarantine policy to the "With Corona" system from late October, Korea Disease Control and Prevention Agency (KDCA) Commissioner Jeong Eun-kyeong said Tuesday.The "With Corona" plan refers to the shift of the quarantine system to focusing on severe patients while letting most ot
A joint research team has confirmed that the risk of end-stage renal disease requiring transplantation or dialysis increases in cancer patients.The team, led by Professors Kim Chang-sung and Kim Su-hwan at Chonnam National University Hospital and Han Kyung-do at Soongsil University, concluded so aft
The first and only targeted therapy to treat hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer with PIK3CA gene mutation arrived in Korea recently.However, it is uncertain whether it can get health insurance benefits.In May, Novart
Hanall Biopharma is one of the most frequently mentioned Korean drugmakers when analysts forecast the arrival of a global blockbuster drug. In developing autoimmune disease treatment candidate HL161(batoclimab), there are many ongoing clinical trials of batoclimab by partners in the U.S. and China t
The number of foreigners getting medical treatment in Korea decreased by more than half last year, a government report said.Thanks to Korean physicians’ excellent techniques, relatively lower hospital bills, and the government’s push to turn the medical industry into another hard-currency earner, th
Sanofi-Aventis Korea has confirmed the safety and efficacy profile of Dupixent (ingredient: dupilumab) in treating children with uncontrolled moderate-to-severe atopic dermatitis in recent studies.The company conducted phase 2/3 LIBERTY AD PRESCHOOL clinical trials with 162 patients aged six months
Locally developed drug pipelines have increased rapidly in the past three years, industry data showed.On Monday, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) released the case study results of new drug pipelines and license transfer conducted for domestic pharmaceutical